Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.00390407138873398 0.0256553262688233
Stock impact report

Dicerna Continues To Advance Partnerships For Its Ever Growing Pipeline [Seeking Alpha]

Dicerna Pharmaceuticals, Inc. (DRNA) 
Last dicerna pharmaceuticals, inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dicerna.com
Company Research Source: Seeking Alpha
Dicerna Continues To Advance Partnerships For Its Ever Growing Pipeline Summary Dicerna Pharmaceuticals established a partnership with Roche for the development of its Hepatitis B product DCR-HBVS. The global Hepatitis B market is expected to reach $3.5 billion by 2021. The main clinical product in the pipeline is DCR-PHXC which is being explored in the pivotal study PHYOX 2 for the treatment of patients with primary hyperoxaluria. Dicerna Pharmaceuticals has $312.7 million in cash as of September 30, 2019 with funds expected to last beyond 2021. DRNA OTCQX:RHHBY Hepatitis B Indication Partnership For DCR-HBVS Dicerna had announced that it formed I think the best part is that Dicerna left itself open to certain options. By that I mean it can choose to co-fund a late-stage study of DCR-HVS for worldwide deployment and a co-promotion option in the U.S. with improved royalties. RNA interference or RNAi is the ability for RNA molecule to inhibit gene expression or translation. It stops th Show less Read more
Impact Snapshot
Event Time:
DRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for DRNA alerts
Opt-in for
DRNA alerts

from News Quantified
Opt-in for
DRNA alerts

from News Quantified